Michelle M. Mezei
University of British Columbia(CA)Vancouver General Hospital(CA)
Publications by Year
Research Areas
Mitochondrial Function and Pathology, Metabolism and Genetic Disorders, Myasthenia Gravis and Thymoma, Amyloidosis: Diagnosis, Treatment, Outcomes, Peripheral Neuropathies and Disorders
Most-Cited Works
- → Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis(2018)2,831 cited
- → A Genome-Wide Association Study of Myasthenia Gravis(2015)218 cited
- → Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy(2023)176 cited
- → Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study(2020)155 cited
- → Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis(2013)141 cited
- → Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study(2022)126 cited
- → SOD1 gene mutations in ALS patients from British Columbia, Canada: Clinical features, neurophysiology and ethical issues in management(2008)80 cited
- → Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations(2008)79 cited
- → Multisystem Disorder in Late-Onset Chronic Progressive External Ophthalmoplegia(2011)60 cited
- → Concurrent inflammatory myopathy and myasthenia gravis with or without thymic pathology: A case series and literature review(2018)41 cited